EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unlocking Neuroprotection: Exercise-Induced Muscle Secretome (Myokines) as a Therapeutic Avenue Against Alzheimer’s Disease Pathogenesis

Hossein Shirvani, Linda S Pescatello, Ali Reza Eftekhari Moghadam, Ehsan Arabzadeh

Journal of Molecular Neuroscience · 10.06.2026 · 76 (2)

DOI: 10.1007/s12031-026-02556-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Molecular Neuroscience, online erschienen am 10.06.2026. Verfasst von Hossein Shirvani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Exercise Physiology Research Center, LifeStyle Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Alzheimer Disease, Exercise, Myokines, Neuroprotective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review critically evaluates exercise-induced myokines as neuroprotective agents against Alzheimer's disease (AD) and is structured around three thematic sections: (1) mechanistic foundations of myokine neuroprotection, (2) translational barriers to therapeutic development, and (3) a strategic framework for future research. Epidemiological studies associate physical exercise with reduced AD risk (30-45%), yet mechanisms remain incompletely resolved. Preclinical studies demonstrate that exercise-induced myokines (Irisin, BDNF, Cathepsin B) modulate AD pathology by: (1) attenuating amyloid-beta (Aβ)/tau accumulation, (2) suppressing neuroinflammation, and (3) enhancing synaptic plasticity. However, human exercise interventions show conflicting results influenced by APOE genotype, age, and exercise modality. Associative human data suggest that Interleukin-6 (IL-6) exemplifies pleiotropy-affording neuroprotective effects in acute contexts but potentially detrimental effects in states of chronic inflammation. Therapeutic hurdles include blood-brain barrier (BBB) penetration, pleiotropic risks, and patient heterogeneity. Emerging concepts such as combinatorial approaches (nanocarriers, exercise mimetics) and biomarker-driven trials are proposed as hypothetical future strategies; however, these remain unvalidated and require substantial preclinical development before implemented in clinical care. This narrative review is structured around three thematic sections: mechanistic foundations of myokine neuroprotection, translational barriers to therapeutic development, and a strategic framework for future research. The muscle-brain axis represents a compelling but complex therapeutic target. Based on current preclinical and correlational human evidence, future research should prioritize mechanistic rigor, standardized biomarker validation, and clinically viable delivery strategies. Notably, several approaches discussed herein-including nanocarrier delivery systems, exercise mimetics, and combinatorial myokine cocktails-remain speculative and are presented as future research directions rather than established therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseExerciseMyokinesNeuroprotective AgentsAnimalsHumansNeuroprotection

Stichwörter der Autor:innen

Muscle-brain axisPatient stratificationPreclinical modelsRecombinant proteinsSynaptic plasticity

Substanzen

MyokinesNeuroprotective Agents

Autor:innen und Institutionen

  • Exercise Physiology Research Center, LifeStyle Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Department of Kinesiology, University of Connecticut, Storrs, CT, USA.
  • Department of Anatomical Science, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Exercise Physiology Research Center, LifeStyle Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. eh.arabzadeh@gmail.com.

Zitieren

APA

Shirvani, H., Pescatello, L. S., Eftekhari Moghadam, A. R., & Arabzadeh, E. (2026). Unlocking Neuroprotection: Exercise-Induced Muscle Secretome (Myokines) as a Therapeutic Avenue Against Alzheimer’s Disease Pathogenesis. Journal of Molecular Neuroscience, 76(2). https://doi.org/10.1007/s12031-026-02556-3

Vancouver

Shirvani H, Pescatello LS, Eftekhari Moghadam AR, Arabzadeh E. Unlocking Neuroprotection: Exercise-Induced Muscle Secretome (Myokines) as a Therapeutic Avenue Against Alzheimer’s Disease Pathogenesis. Journal of Molecular Neuroscience. 2026;76(2). doi:10.1007/s12031-026-02556-3

BibTeX
@article{Shirvani2026,
  author = {Shirvani, Hossein and Pescatello, Linda S and Eftekhari Moghadam, Ali Reza and Arabzadeh, Ehsan},
  title = {Unlocking Neuroprotection: Exercise-Induced Muscle Secretome (Myokines) as a Therapeutic Avenue Against Alzheimer’s Disease Pathogenesis},
  journal = {Journal of Molecular Neuroscience},
  year = {2026},
  volume = {76},
  number = {2},
  doi = {10.1007/s12031-026-02556-3}
}
Kostenlos starten →